Literature DB >> 4073444

[Prognostic significance of a preoperative risk check list].

P M Osswald, H J Hartung, U Feldmann.   

Abstract

The perioperative risk of lethal complications amounts to 0.02 to 0.4% dependent on different investigators. A further decrease of this perioperative risk has failed to occur in spite of most sophisticated methods of anesthesiology. We desire a safe classification of risk scores in order to calculate the prognosis of the individual patient who is scheduled for operation and anaesthesia. 15 anamnestical, clinical and blood chemistry data of 700 patients planned for general surgery were registered, intra- and postoperative complications were documented, and by means of statistical methods (discriminant analysis) evaluated. The patients' data were registered from the date of premedication to discharge or to four weeks after operation. To define the complications they were classified as mild, moderate and severe complications. The 15 variables used show a calculated risk prognosis of 40% for mild, 57% for moderate and 79% for severe complications. We find a very good correlation of the calculated versus observed risk of complications. The risk of mild complications are underestimated and severe complications overestimated.

Entities:  

Mesh:

Year:  1985        PMID: 4073444

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  3 in total

1.  [Quantifications of perioperative risk].

Authors:  C Ohmann; W Lorenz
Journal:  Langenbecks Arch Chir       Date:  1987

Review 2.  [Biomedical and clinimetric approaches in determining the causes of perioperative risk: developing a German ASA classification].

Authors:  W Lorenz; W Dick; T Junginger; C Ohmann; A Doenicke; M Rothmund
Journal:  Langenbecks Arch Chir       Date:  1987

3.  A cross-validated multifactorial index of perioperative risks in adults undergoing anaesthesia for non-cardiac surgery. Analysis of perioperative events in 26907 anaesthetic procedures.

Authors:  B Schwilk; R Muche; H Treiber; A Brinkmann; M Georgieff; U Bothner
Journal:  J Clin Monit Comput       Date:  1998-05       Impact factor: 2.502

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.